ArticleClinical research in cardiology : official journal of the German Cardiac Society2016
Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.
- Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy.Circulation. Arrhythmia and electrophysiology · 2025Pooled it
- Long-Term Follow-Up of the S-ICD: A 10-Years Follow-Up Study of a Large Single Center Cohort.Pacing and clinical electrophysiology : PACE · 2025Article
- Ventricular arrhythmias and the role of antitachycardia pacing in patients with electrical heart disease and hypertrophic cardiomyopathy.International journal of cardiology. Congenital heart disease · 2025Article
- The new European Society of Cardiology guideline for the management of cardiomyopathies: key messages for cardiac electrophysiologists.Herzschrittmachertherapie & Elektrophysiologie · 2023Review
- Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy.Cardiology research and practice · 2023Article
- Performance of the entirely subcutaneous ICD in borderline indications.Clinical research in cardiology : official journal of the German Cardiac Society · 2020Article
- Outcome differences and device performance of the subcutaneous ICD in patients with and without structural heart disease.Clinical research in cardiology : official journal of the German Cardiac Society · 2020Article
- Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population.Clinical research in cardiology : official journal of the German Cardiac Society · 2019Article
- Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest.Clinical research in cardiology : official journal of the German Cardiac Society · 2019Observational
- Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion.Clinical research in cardiology : official journal of the German Cardiac Society · 2019Article
- The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience.Cardiology journal · 2019Article
- Device updates successfully reduce T‑wave oversensing and inappropriate shocks in subcutaneous ICD patients.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2018Article
- Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.Clinical research in cardiology : official journal of the German Cardiac Society · 2018Article
- [Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].Herzschrittmachertherapie & Elektrophysiologie · 2018Review
- The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.Clinical research in cardiology : official journal of the German Cardiac Society · 2018Article
- Analysis of Screening Electrocardiogram for the Subcutaneous Defibrillator in Adults with Congenital Heart Disease.Pediatric cardiology · 2017Article
- Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications.Annals of cardiothoracic surgery · 2017Review
- Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems.Clinical research in cardiology : official journal of the German Cardiac Society · 2017Article
- Update on hypertrophic cardiomyopathy and a guide to the guidelines.Nature reviews. Cardiology · 2016Review
- [Updated ESC guideline: innovations for the treatment of ventricular arrhythmias and recommendations for prevention of sudden cardiac death].Herzschrittmachertherapie & Elektrophysiologie · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe totally subcutaneous implantable defibrillator (S-ICD) was introduced as a new alternative to conventional implantable defibrillators and is employed worldwide. This system is especially attractive for young patients. However, in patients with hypertrophic cardiomyopathy (HCM), T-wave oversensing may occur. To address the question whether the S-ICD system is suitable for HCM patients, the data of a standard of care prospective single-center S-ICD registry were evaluated. METHODS AND
resultsIn the present study, 18 HCM patients who received an S-ICD for primary (n = 14) or secondary prevention (n = 4) and a minimal follow-up duration of 6 months were analyzed. The mean follow-up duration was 31.7 ± 15.4 months. Ventricular arrhythmias were adequately detected in 4 patients (22%). In 7 patients (39%), T-wave oversensing was noticed and led to at least one inappropriate shock in 4 patients (22%). Further adverse events included surgical revision due to a mobile sensing electrode and resulting noise detection as well as one case of early battery failure requiring pulse generator change.
conclusionPatients with HCM and S-ICD systems have an increased risk of T-wave oversensing and inappropriate shock delivery. Thorough monitoring as well as exercise tests may help to improve device settings and thereby prevent T-wave oversensing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.